Mandatory Notification of Trade

21.11.2005 – Jamie Mather (through the company Nexus), Vice President and co-founder of Meridian International Group (MIG), and Daniel Laroque (through the company Cleverling), President and co-founder of MIG and board member of Nutri Pharma ASA, have on...

Read more about Mandatory Notification of Trade

Extraordinary general meeting

25.11.2004 - The Extraordinary General Meeting of Nutri Pharma ASA today elected Knut Skabo to the Board of Directors. The decision was unanimous....

Read more about Extraordinary general meeting

Third Quarter Report 2005

17.11.2005 – Nutri Pharma ASA (OSE: NUT) today reports revenues of NOK 19 mill in Q3 vs NOK 1.2 mill. in Q3 2004. As previously announced, Nutri Pharma ASA acquired 100% of the shareholding in Meridian International Group (MIG) with effect per 1 July 2005...

Read more about Third Quarter Report 2005

Management change

04.11.2004 - As a result of the change in strategic focus announced in NUT`s Q3 report, the Board of Directors and CEO Eirik Ubøe have agreed that Ubøe is to leave is position as CEO of NUT....

Read more about Management change

Protokoll eks.ordinær generalforsamling

28.10.2005 - Generalforsamlingen i Nutri Pharma ASA har i dag den 28. oktober 2005 besluttet styrets forslag til vedtak i overenstemmelse med selskapets innkalling til aksjonærene sendt 14. oktober....

Read more about Protokoll eks.ordinær generalforsamling

Third Quarter Results 2004

19.10.2004 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for the first nine months of 2004 was NOK 9.8 million compared to a loss of NOK 8.5 million in the same period 2003....

Read more about Third Quarter Results 2004

New date for Q3 2005 reporting

20.10.20005 - Nutri Pharma ASA announces that the Q3 2005 financial results will be released on 17 November 2005. ...

Read more about New date for Q3 2005 reporting

NUT details for offer to aquire all outstanding shares

19.10.2004 - As announced on 14 October, Lars H. Høie has informed Nutri Pharma that he will make an offer to acquire all the outstanding shares in Nutri Pharma....

Read more about NUT details for offer to aquire all outstanding shares

Notice of Extraordinary General Meeting

14.10.2005 - An Extraordinary General Meeting of Nutri Pharma ASA will be held Friday 28 Oct. 2005, 10:00 a.m., offices of Nutri Pharma ASA, Kronprinsesse Märthas plass 1, Oslo, Norway....

Read more about Notice of Extraordinary General Meeting

Opposition filed against a granted

01.09.2004 - NUT has been informed by the European Patent Office (EPO) that the EPO has received notice of opposition concerning a patent that has been granted to NUT for the European territory.....

Read more about Opposition filed against a granted

Amendment of terms regarding acquisition of MIG

29.09.2005 - Nutri Pharma ASA announces today amendment of certain terms in the agreement relating to acquisition of 100% of MIG, as announced by Nutri Pharma 2 June 2005....

Read more about Amendment of terms regarding acquisition of MIG

First half results 2004

23.04.2004 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for the first half of 2004 was NOK 6.5 million compared to a profit of NOK 1.1 million in the first half of 2003....

Read more about First half results 2004

First Half Report 2005

24.08.2005 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for the second quarter of 2005 was NOK -6,0 million compared to a loss of NOK -3,3 million in the second quarter of 2004....

Read more about First Half Report 2005

Nutri Pharma has engaged

13.05.2004 - Nutri Pharma ASA has engaged Enskilda Securities to assist it in exploring and developing strategic alternatives.....

Read more about Nutri Pharma has engaged

Nutri Pharma ASA acquires 100% of Meridian International Group Ltd.

02.06.2005 - Nutri Pharma ASA announces today that it entered into an agreement on 1 June, 2005 to acquire 100% of the shares of the company Meridian International Group Ltd. (`MIG`)....

Read more about Nutri Pharma ASA acquires 100% of Meridian International Group Ltd.

First quarter results 2004

27.04.2004 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for the first 3 months of 2004 was NOK 3.2 million compared to a profit of NOK 3.1 million in the first quarter of 2003. ....

Read more about First quarter results 2004

Fourth quarter and preliminary results 2003

04.02.2004 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for 2003 was NOK 10.5 million compared to a loss of NOK 66.6 million in 2002....

Read more about Fourth quarter and preliminary results 2003

Annual General Meeting

16.03.2005 - The Annual General Meeting (AGM) of Nutri Pharma ASA today approved the Board of Directors` proposal for annual accounts and directors` report including the Board of Directors` proposal for coverage of the loss for 2004.....

Read more about Annual General Meeting

Licence Agreement with Allied Bakeries

16.01.2004 - Nutri Pharma ASA (OSE: NUT) has entered into licence agreement with Allied Bakeries - the leading bread manufacturer in the UK....

Read more about Licence Agreement with Allied Bakeries

Product Approval for Nutri Pro (Nutrilett) in Russia

14.03.2005 - Nutri Pharma ASA announces today that product approval for its soy based health and weight reduction product, sold under the trademark Nutrilett in the Nordic countries....

Read more about Product Approval for Nutri Pro (Nutrilett) in Russia

NUT Annual Report 2005

03.05.2005 - Nutri Pharma ASA`s Annual report for 2005 is approved by the Board of Directors . The 44 page report is available for download in Adobe Acrobat format below....

Read more about NUT Annual Report 2005

Notice of Annual General Meeting

02.03.2005 - The annual general meeting of Nutri Pharma ASA will be held Tuesday 15 March 2005, 5:00 p.m., offices of Vogt & Wiig advokatfirma, Roald Amundsensgt. 6, Oslo, Norway....

Read more about Notice of Annual General Meeting

Nutri Pharma Patent upheld by European Patent Office

08.02.2005 - The Opposition Division of the European Patent Office has announced that Nutri Parma’s European Patent, No. 0902624, is valid under the European Patent Convention and has both novelty and inventive merit....

Read more about Nutri Pharma Patent upheld by European Patent Office

Fourth Quarter and Financial Results 2004

02.02.2005 - Nutri Pharma ASA (OSE: NUT) today announced that its loss for 2004 was NOK 10.7 million compared to a loss of NOK 10.5 million in 2003....

Read more about Fourth Quarter and Financial Results 2004